Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Joseph M Geskey, Neal J Thomas & Gretchen L Brummel. (2007) Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV). Biologics: Targets and Therapy 1:1, pages 33-43.
Read now
Read now
Articles from other publishers (16)
Simone Trist, Emily Horsley, Hala Katf, Natalie Tasker & Mona Mostaghim. (2018) Improving the prescribing of palivizumab. Journal of Paediatrics and Child Health 54:12, pages 1353-1356.
Crossref
Crossref
Nusrat Homaira, William Rawlinson, Thomas L. Snelling & Adam Jaffe. (2014) Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective. International Journal of Pediatrics 2014, pages 1-13.
Crossref
Crossref
Ilker Uçkay, Paola M. Gasche-Soccal, Laurent Kaiser, Richard Stern, Jesica Mazza-Stalder, John-David Aubert & Christian van Delden. (2010) Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy. The Journal of Heart and Lung Transplantation 29:3, pages 299-305.
Crossref
Crossref
Jill A. Hoffman. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
1058
1082
.
. 2009. Emerging Issues and Controversies in Infectious Disease. Emerging Issues and Controversies in Infectious Disease
103
112
.
Maria Rotzén Östlund, Annika Tiveljung Lindell, Sofia Stenler, Hilde M. Riedel, Benita Zweygberg Wirgart & Lena Grillner. (2007) Molecular epidemiology and genetic variability of respiratory syncytial virus (RSV) in Stockholm, 2002–2003. Journal of Medical Virology 80:1, pages 159-167.
Crossref
Crossref
Alexander C. Schmidt. 2007. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
999
1031
.
N. Fujita, M. Kaito, H. Tanaka, S. Horiike, N. Urawa, R. Sugimoto, M. Konishi, S. Watanabe & Y. Adachi. (2005) Hepatitis C virus free‐virion and immune‐complex dynamics during interferon therapy with and without ribavirin in genotype‐1b chronic hepatitis C patients. Journal of Viral Hepatitis 13:3, pages 190-198.
Crossref
Crossref
Allan R. Glanville, Andrew I.R. Scott, Judith M. Morton, Christina L. Aboyoun, Marshall L. Plit, Ian W. Carter & Monique A. Malouf. (2005) Intravenous Ribavirin Is a Safe and Cost-effective Treatment for Respiratory Syncytial Virus Infection After Lung Transplantation. The Journal of Heart and Lung Transplantation 24:12, pages 2114-2119.
Crossref
Crossref
Todd D. Barton & Emily A. Blumberg. (2005) Viral Pneumonias Other Than Cytomegalovirus in Transplant Recipients. Clinics in Chest Medicine 26:4, pages 707-720.
Crossref
Crossref
L Navér, M Eriksson, U Ewald, A Linde, M Lindroth & J Schollin. (2007) Appropriate prophylaxis with restrictive palivizumab regimen in preterm children in Sweden. Acta Paediatrica 93:11, pages 1470-1473.
Crossref
Crossref
Jeremy D. Flynn, Wendell S. Akers, Mikael Jones, Natasa Stevkovic, Thomas Waid, Timothy Mullett & Salik Jahania. (2012) Treatment of Respiratory Syncytial Virus Pneumonia in a Lung Transplant Recipient: Case Report and Review of the Literature. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 24:7, pages 932-938.
Crossref
Crossref
APARNA K. MOHAN, M. MILES BRAUN, SUSAN ELLENBERG, JUDITH HEDJE & TIMOTHY R. COTÉ. (2004) Deaths among children less than two years of age receiving palivizumab: an analysis of comorbidities. The Pediatric Infectious Disease Journal 23:4, pages 342-345.
Crossref
Crossref
EWA HENCKEL, JOACHIM LUTHANDER, EVA BERGGREN, HANNA KAPADIA, LARS NAV??R, MIKAEL NORMAN, RUTGER BENNET & MARGARETA ERIKSSON. (2004) Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002. The Pediatric Infectious Disease Journal 23:1, pages 27-31.
Crossref
Crossref
Rodrigo Morales, Michael Kirkpatrick, Barry Browne & Osemwegie Emovon. (2015) Respiratory Syncytial Virus Pneumonia in an Adult Renal Transplant Patient: An Unexpected Nosocomial Infection. Infection Control & Hospital Epidemiology 24:7, pages 548-550.
Crossref
Crossref
Paul F Torrence & Linda D Powell. (2016) The Quest for an Efficacious Antiviral for Respiratory Syncytial Virus. Antiviral Chemistry and Chemotherapy 13:6, pages 325-344.
Crossref
Crossref